Mesenchymal stem cell therapy for immune-modulation: the donor, the recipient, and the drugs in-between

Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

(2013) Joanne Kurtzberg et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells

(2013) Georg Siegel et al.   BMC Medicine

Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures

(2013) Mariluz P. Mojica-Henshaw et al.   CYTOTHERAPY

Heparin concentration is critical for cell culture with human platelet lysate

(2013) Hatim Hemeda et al.   CYTOTHERAPY

Pooled human platelet lysate versus fetal bovine serum—investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use

(2013) Stig-Frederik Trojahn Kølle et al.   CYTOTHERAPY

Mesenchymal stem cell therapy in skin: why and what for?

(2013) Kiarash Khosrotehrani   EXPERIMENTAL DERMATOLOGY

Potential mesenchymal stem cell therapy for skin diseases

(2013) Xiaoguang Li et al.   EXPERIMENTAL DERMATOLOGY

Heterogeneity of the biological properties and gene expression profiles of murine bone marrow stromal cells

(2013) Junxia Lei et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Alterations in the Cellular Immune Compartment of Patients Treated with Third-Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation

(2013) Regina Jitschin et al.   STEM CELLS

Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia–reperfusion injury

(2013) Yen-Ta Chen et al.   Stem Cell Research & Therapy

Mesenchymal Stem Cells: Are We Ready for Clinical Application in Transplantation and Tissue Regeneration?

(2013) Martin J. Hoogduijn et al.   Frontiers in Immunology

Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells

(2012) Merve Zaim et al.   ANNALS OF HEMATOLOGY

Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy

(2012) Donald G. Phinney   JOURNAL OF CELLULAR BIOCHEMISTRY

A Mesenchymal Stromal Cell Gene Signature for Donor Age

(2012) Hugo Alves et al.   PLoS One

Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells

(2012) Masato Kubo et al.   Frontiers in Immunology

Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function

(2011) Heba Abdelrazik et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Aging alters tissue resident mesenchymal stem cell properties

(2011) Eckhard U. Alt et al.   Stem Cell Research

Pretreatment with Interferon-γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis

(2011) Marjolijn Duijvestein et al.   STEM CELLS

Immune Reactions following Cord Blood Transplantations in Adults

(2011) Hiroto Narimatsu   Stem Cells International

Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?

(2010) Antonio Uccelli et al.   CURRENT OPINION IN IMMUNOLOGY

Identification of growth and attachment factors for the serum-free isolation and expansion of human mesenchymal stromal cells

(2010) Sunghoon Jung et al.   CYTOTHERAPY

Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells

(2010) Rosa Yañez et al.   EXPERIMENTAL CELL RESEARCH

Human Mesenchymal Stem Cells Modulate Cellular Immune Response to Islet Antigen Glutamic Acid Decarboxylase in Type 1 Diabetes

(2010) Maria M. Zanone et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone marrow stromal cells use TGF-  to suppress allergic responses in a mouse model of ragweed-induced asthma

(2010) K. Nemeth et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts

(2010) E. Eggenhofer et al.   TRANSPLANT IMMUNOLOGY

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2

(2009) G. M. Spaggiari et al.   BLOOD

Cell contact, prostaglandin E2and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+regulatory T cells

(2009) K. English et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Mesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophages

(2009) Jaehyup Kim et al.   EXPERIMENTAL HEMATOLOGY

Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow

(2009) Karen Bieback et al.   STEM CELLS

Twenty Years of Unrelated Donor Hematopoietic Cell Transplantation for Adult Recipients Facilitated by the National Marrow Donor Program

(2008) Chatchada Karanes et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors

(2008) M. L. MacMillan et al.   BLOOD

IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

(2008) David Polchert et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production

(2008) Krisztián Németh et al.   NATURE MEDICINE

Susceptibility of Human Mesenchymal Stem Cells to Tacrolimus, Mycophenolic Acid, and Rapamycin

(2008) Martin J. Hoogduijn et al.   TRANSPLANTATION